Galectin Therapeutics Inc. (GALT)
NASDAQ: GALT · Real-Time Price · USD
2.320
-0.050 (-2.11%)
At close: Apr 28, 2026, 4:00 PM EDT
2.420
+0.100 (4.31%)
After-hours: Apr 28, 2026, 4:47 PM EDT
Galectin Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 5.8 | 5.86 | 5.94 | 6.62 | 6.36 | |
| Research & Development | 14.29 | 36.57 | 32.13 | 31.74 | 23.82 | |
| Operating Expenses | 20.09 | 42.43 | 38.07 | 38.35 | 30.18 | |
| Operating Income | -20.09 | -42.43 | -38.07 | -38.35 | -30.18 | |
| Interest Expense | -7.33 | -5.54 | -2.79 | -1.03 | -0.49 | |
| Interest & Investment Income | 0.13 | 0.34 | 0.23 | 0.05 | 0 | |
| Other Non Operating Income (Expenses) | -3.55 | 0.59 | -0.43 | 0.56 | 0.14 | |
| Pretax Income | -30.84 | -47.05 | -41.07 | -38.78 | -30.53 | |
| Net Income | -30.84 | -47.05 | -41.07 | -38.78 | -30.53 | |
| Preferred Dividends & Other Adjustments | 0.14 | 0.15 | 3.74 | 0.1 | 0.17 | |
| Net Income to Common | -30.97 | -47.2 | -44.81 | -38.87 | -30.7 | |
| Shares Outstanding (Basic) | 64 | 62 | 60 | 59 | 59 | |
| Shares Outstanding (Diluted) | 64 | 62 | 60 | 59 | 59 | |
| Shares Change (YoY) | 2.56% | 3.57% | 1.29% | 1.48% | 2.63% | |
| EPS (Basic) | -0.48 | -0.76 | -0.74 | -0.65 | -0.52 | |
| EPS (Diluted) | -0.48 | -0.76 | -0.74 | -0.65 | -0.52 | |
| EBIT | -20.09 | -42.43 | -38.07 | -38.35 | -30.18 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.